Background: Polypharmacy is very common in older persons and it is associated with inappropriate prescribing and potential drug-drug interactions (DDIs). Aims of this study were to identify prevalence of DDIs in older persons with acute stroke and to evaluate the association between stroke and DDIs. Methods: One hundred forty-six patients admitted with diagnosis of acute stroke were enrolled. The therapeutic regimen of patients was analyzed at admission to identify the number of DDIs, prevalence and sorts of serious DDIs according to subtype of acute stroke (ischemic or hemorrhagic) and to its recurrence. Results: Five hundred eighty-two DDIs were identified: 18 mild, 415 moderate and 149 serious. Sixty-one percent of patients were exposed to at least one serious DDI. A higher percentage of patients were exposed to at least one serious DDI among those with a recurring ischemic event compared to those with a first event (74 vs. 50%; p < 0.01, respectively). Serious DDIs potentially associated with an increased risk of a cerebral event were identified in 19 (17%) patients with ischemic stroke, and in 7 (19%) patients with hemorrhagic stroke. Conclusions: The prevalence of serious DDIs was high in aging patients with acute stroke but different according to subtype and recurrence of the cerebrovascular event.

Keywords:
Polytherapy, Drugs–drugs interaction, Stoke, Aging
1.
Onder G, Bonassi S, Abbatecola AM, Folino-Gallo P, Lapi F, Marchionni N, Pani L, Pecorelli S, Sancarlo D, Scuteri A, Trifirò G, Vitale C, Zuccaro SM, Bernabei R, Fini M; Geriatrics Working Group of the Italian Medicines Agency: High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci 2014;69:430-437.
2.
Marengoni A, Onder G: Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. BMJ 2015;350:h1059.
3.
Marengoni A, Nobili A, Onder G: Best practices for drug prescribing in older adults: a call for action. Drugs Aging 2015;32:887-890.
4.
Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM: Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx 2005;2:554-571.
5.
Nobili A, Pasina L, Tettamanti M, Lucca U, Riva E, Marzona I, Monesi L, Cucchiani R, Bortolotti A, Fortino I, Merlino L, Walter Locatelli G, Giuliani G: Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther 2009;34:377-386.
6.
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-19.
7.
Petrovic M, van der Cammen T, Onder G: Adverse drug reactions in older people: detection and prevention. Drugs Aging 2012;29:453-462.
8.
Pasina L, Marengoni A, Ghibelli S, Suardi F, Djade CD, Nobili A, Franchi C, Guerrini G: A multicomponent intervention to optimize psychotropic drug prescription in elderly nursing home residents: an Italian multicenter, prospective, pilot study. Drugs Aging 2016;33:143-149.
9.
Ghibelli S, Marengoni A, Djade CD, Nobili A, Tettamanti M, Franchi C, Caccia S, Giovarruscio F, Remuzzi A, Pasina L: Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck(®)). Drugs Aging 2013;30:821-828.
10.
Dewey HM, Donnan GA, Freeman EJ, Sharples CM, Macdonell RA, McNeil JJ, Thrift AG: Interrater reliability of the national institutes of health stroke scale: rating by neurologists and nurses in a community-based stroke incidence study. Cerebrovasc Dis 1999;9:323-327.
11.
Vincent JL, Moreno R: Clinical review: scoring system in the critically ill. Crit Care 2010;14:207.
12.
Hudon C, Fortin M, Vanasse A: Cumulative illness rating scale was a reliable and valid index in a family practice context. J Clin Epidemiol 2005;58:603-608.
13.
Uyttenboogaart M, Stewart RE, Vroomen PC, De Keyser J, Luijckx GJ: Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials. Stroke 2005;36:1984-1987.
14.
SPSS Inc.: SPSS Base 18.0.3 for MAC User's Guide. Chicago, SPSS Inc., 2010.
15.
Dumbreck S, Flynn A, Nairn M, Wilson M, Treweek S, Mercer SW, Alderson P, Thompson A, Payne K, Guthrie B: Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ 2015;350:h949.
16.
Petrovic M, van der Cammen T, Onder G: Adverse drug reactions in older people: detection and prevention. Drugs Aging 2012;29:453-462.
17.
O'Connor MN, Gallagher P, O'Mahony D: Inappropriate prescribing: criteria, detection and prevention. Drugs Aging 2012;29:437-452.
18.
Hill-Taylor B, Sketris I, Hayden J, Byrne S, O'Sullivan D, Christie R: Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther 2013;38:360-372.
19.
Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH: Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf 2007;16:641-651.
20.
Marengoni A, Bonometti F, Nobili A, Tettamanti M, Salerno F, Corrao S, Iorio A, Marcucci M, Mannucci PM; Italian Society of Internal Medicine (SIMI) Investigators: In-hospital death and adverse clinical events in elderly patients according to disease clustering: the REPOSI study. Rejuvenation Res 2010;13:469-477.
21.
Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT: Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370:173-184.
22.
Focks JJ, Brouwer MA, van Oijen MG, Lanas A, Bhatt DL, Verheugt FW: Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome - a systematic review. Heart 2013;99:520-527.
23.
Schedlbauer A, Prasad V, Mulvaney C, Phansalkar S, Stanton W, Bates DW, Avery AJ: What evidence supports the use of computerized alerts and prompts to improve clinicians' prescribing behavior? J Am Med Inform Assoc 2009;16:531-538.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.